Literature DB >> 17701441

Expression of the HPV11 E2 gene in transgenic mice does not result in alterations of the phenotypic pattern.

Kerstin Leykauf1, Kirsten Kabsch, Nikolaus Gassler, Lutz Gissmann, Angel Alonso, Johannes Schenkel.   

Abstract

The E2 early protein of human papillomaviruses (HPV) has been found associated with the mitotic spindle therefore being implicated in the partition of the replicated viral DNA to daughter cells. In addition, E2 proteins bind to the upstream regulatory region of the virus and to cellular promoters modulating thereby cellular transcription and differentiation. In many cervical cancers, the E2 reading frame is interrupted upon incorporation of the viral genome into the host DNA. This results in the loss of the E2 mediated transcriptional repression and uncontrolled expression of the viral oncogenes. All these results have been obtained in transfected cells but no information is available on the E2 effects in the context of the entire organism. Transgenic mice were generated expressing the E2 protein of HPV11 under the control of the Ubiquitin C promoter. E2 mRNA is present in all mice tissues analysed and the E2 protein expressed in the skin (the target tissue of HPV11) was shown by Western blotting, albeit at a very low level. Analysis of the transgenic mice shows no major histological changes in the skin or all other tissues investigated. These data indicate that in transgenic mice the human papillomavirus type 11 E2 does not grossly modulate cellular proliferation or differentiation events.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701441     DOI: 10.1007/s11248-007-9130-y

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  35 in total

1.  Ubiquitin protein ligase Nedd4 binds to connexin43 by a phosphorylation-modulated process.

Authors:  Kerstin Leykauf; Mojibrahman Salek; Jörg Bomke; Matthias Frech; Wolf-Dieter Lehmann; Matthias Dürst; Angel Alonso
Journal:  J Cell Sci       Date:  2006-09-01       Impact factor: 5.285

2.  Subunit affinities and stoichiometries of the human papillomavirus type 11 E1:E2:DNA complex.

Authors:  S F Chao; W J Rocque; S Daniel; L E Czyzyk; W C Phelps; K A Alexander
Journal:  Biochemistry       Date:  1999-04-06       Impact factor: 3.162

3.  Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8.

Authors:  Inke Diana Schaper; Gian Paolo Marcuzzi; Sönke Jan Weissenborn; Hans Udo Kasper; Volker Dries; Neil Smyth; Pawel Fuchs; Herbert Pfister
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

Review 4.  Control of papillomavirus DNA replication and transcription.

Authors:  C Desaintes; C Demeret
Journal:  Semin Cancer Biol       Date:  1996-12       Impact factor: 15.707

5.  Mitotic kinesin-like protein 2 binds and colocalizes with papillomavirus E2 during mitosis.

Authors:  Ting Yu; Yu-Cai Peng; Elliot J Androphy
Journal:  J Virol       Date:  2006-11-29       Impact factor: 5.103

Review 6.  Transgenic animal models of human papillomavirus-dependent disease (Review).

Authors:  R L Eckert; J F Crish; S Balasubramanian; E A Rorke
Journal:  Int J Oncol       Date:  2000-05       Impact factor: 5.650

7.  JunB and Bcl-2 overexpression results in protection against cell death of nigral neurons following axotomy.

Authors:  Christine Winter; Christoph Weiss; Ana Martin-Villalba; Manfred Zimmermann; Johannes Schenkel
Journal:  Brain Res Mol Brain Res       Date:  2002-08-15

8.  The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes.

Authors:  Monika Oldak; Hans Smola; Monique Aumailley; Francisco Rivero; Herbert Pfister; Sigrun Smola-Hess
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning.

Authors:  Brian A Van Tine; Luan D Dao; Shwu-Yuan Wu; Timothy M Sonbuchner; Biing Yuan Lin; Nianxiang Zou; Cheng-Ming Chiang; Thomas R Broker; Louise T Chow
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-12       Impact factor: 11.205

10.  Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein.

Authors:  Caroline Demeret; Alejandro Garcia-Carranca; Françoise Thierry
Journal:  Oncogene       Date:  2003-01-16       Impact factor: 9.867

View more
  5 in total

1.  Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression.

Authors:  Sophie Bellanger; Chye Ling Tan; Yue Zhen Xue; Sébastien Teissier; Françoise Thierry
Journal:  Am J Cancer Res       Date:  2011-01-24       Impact factor: 6.166

2.  The human papillomavirus type 18 E2 protein is a cell cycle-dependent target of the SCFSkp2 ubiquitin ligase.

Authors:  Sophie Bellanger; Chye Ling Tan; Wenlong Nei; Ping Ping He; Françoise Thierry
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

Review 3.  The papillomavirus E2 proteins.

Authors:  Alison A McBride
Journal:  Virology       Date:  2013-07-10       Impact factor: 3.616

4.  Expression of mitochondrial non-coding RNAs (ncRNAs) is modulated by high risk human papillomavirus (HPV) oncogenes.

Authors:  Claudio Villota; América Campos; Soledad Vidaurre; Luciana Oliveira-Cruz; Enrique Boccardo; Verónica A Burzio; Manuel Varas; Jaime Villegas; Luisa L Villa; Pablo D T Valenzuela; Miguel Socías; Sally Roberts; Luis O Burzio
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

5.  Stranglehold on the spindle assembly checkpoint: the human papillomavirus E2 protein provokes BUBR1-dependent aneuploidy.

Authors:  Chye Ling Tan; Sébastien Teissier; Jayantha Gunaratne; Ling Shih Quek; Sophie Bellanger
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.